Myocardial revascularization in patients with stable coronary arterydisease: the stratification of perioperative and long-term risks

Authors: Sokolova N.Yu.1, Golukhova E.Z.2

Company: 1) Tver «Regional clinical hospital»; Peterburgskoe shosse, 105, Tver', Region Tver', 170036, Russian Federation;

2) A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation; Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

For correspondence:  Sign in or register.


For citation: N.Yu. Sokolova, E.Z. Golukhova; Myocardial revascularization in patients with stable coronary artery disease: the stratification of perioperative and long-term risks; Kreativnaya Kardiologiya. 2016; 10 (1): 25-36 (in Russian)

Keywords: coronary artery disease coronary artery bypass grafting percutaneous coronary intervention risk stratification EuroSCORE II SYNTAX Score

Full text:  



The problem of treatment of coronary artery disease (CAD) remains one of the most urgent and priority problems of global and national health care. In recent decades, myocardial revascularization has been regarded as the most effective method for the treatment of CAD. What kind of treatment strategy is more preferable for a patient – drug therapy, coronary bypass grafting or percutaneous coronary intervention should be dependent on the ratio of «riskbenefit» of these types of treatment and evaluation of operative mortality risk. Numerous models have been developed for risk stratification, with a focus on anatomical complexity of the lesions or clinical risks. The article analyzes the current state of selecting the best treatment strategies and stratification of operational risks in patients with stable CAD. We have tried to analyze the updated recommendations of the European Society of Cardiology (ESC) and the European Association of Cardiothoracic Surgeons (EACTS) in 2014.


  1. Bockeria L.A., Alekyan B.G. Textbook of endovascular surgery for cardiovascular diseases. Moscow: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences; 2013. Vol. 3 (in Russian).

  2. Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann. Thorac. Cardiovasc. Surg. 2003; 9: 365—70.

  3. Head S.J., Kaul S., Mack M.J., Serruys P.W., Taggart D.P., Holmes D.R., Jr. et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur. Heart J. 2013; 34 (32): 2510-8.

  4. Bockeria L.A., Bockeria O.L., Kudzoe- va Z.F. Comparative analysis of PCI vs CABG in stable ischemic heart disease: overview of the prob­lem and status update. Annaly khirurgii. 2009; 6: 10-23 (in Russian).

  5. Head S.J., Holmes D.R., Jr., Mack M.J., Ser­ruys P. W., Mohr F.W., Morice M.C. et al. Risk pro­file and 3-year outcomes from the SYNTAX percu­taneous coronary intervention and coronary artery bypass grafting nested registries. JACC. Cardiovasc. Interv. 2012; 5 (6): 618-25.

  6. Nilsson J., Algotsson L., Hoglund P. et al. Compari­son of 19 preoperative risk stratification models in open-heart surgery. Eur. Heart J. 2006; 27: 867—74.

  7. European System for Cardiac Operative Risk Evaluation. (дата обраще­ния - 15.01.2016).

  8. Roques F., Michel P., Goldstone A.R., Nashef S.A. The logistic EuroScORE. Eur. Heart. J. 2003; 24 (9): 881-2.

  9. Nashef S.A., Roques F., Michel P, Gauducheau E., Lemeshow S., Salamon R. European system for car­diac operative risk evaluation (EuroSCORE). Eur. J. Cardiothorac. Surg. 1999; 16 (1): 9-13.

  10. Siregar S, Groenwold R.H., de Heer F., Bots M.L., van der Graaf Y, van Herwerden L.A. Performance of the original EuroSCORE. Eur. J. Cardiothorac. Surg. 2012; 41 (4): 746-54.

  11. Hickey G.L., Grant S.W., Murphy G.J., Bhabra M., Pagano D., McAllister K. et al. Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur. J. Cardiothorac. Surg. 2013; 43 (6): 1146-52.

  12. Nashef S.A., Roques F., Sharples L.D., Nilsson J., Smith C., Goldstone A.R., Lockowandt U. EuroSCORE II. Eur. J. Cardiothorac. Surg. 2012; 41 (4): 734-44; discussion 744-45.

  13. BiancariF., VasquesF., Mikkola R., Martin M., Lahti- nen J., Heikkinen J. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. Ann. Thorac. Surg. 2012; 93 (6): 1930-5.

  14. Chalmers J., Pullan M., Fabri B., McShane J., Shaw M., Mediratta N., Poullis M. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur. J. Cardiothorac. Surg. 2013; 43 (4): 688-94.

  15. Grant S.W., Hickey G.L., Dimarakis I., Trivedi U., Bryan A., Treasure T. et al. How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23 740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. Heart. 2012; 98 (21): 1568-72.

  16. Kalender M., Adademir T., Tasar M., Ecevit A.,Karaca O., Salihi S. et al. Validation of EuroSCORE II risk model for coronary artery bypass surgery in high-risk patients. Kardiochirurgia i Torakochirurgia Polska. 2014; 11 (3): 252-6.

  17. Moscarelli M., Bianchi G., Margaryan R., Cerillo A.,Farneti P., Murzi M. et al. Accuracy ofEuroSCORE II in patients undergoing minimally invasive mitral valve surgery. Interact. Cardiovasc. Thorac. Surg. 2015; 21 (6): 748-53.
  18. Youssefi P, Timbrell D., Valencia O., Gregory P., Vlachou C., Jahangiri M. et al. Predictors of Failure in Fast-Track Cardiac Surgery. J. Cardiothorac. Vasc. Anesth. 2015; 29 (6): 1466-71.

  19. Carnero-Alcazar M., Silva Guisasola J.A., Reguillo Lacruz F.J., Maroto Castellanos L.C., Cobiella Carnicer J., Villagran Medinilla E. et al. Validation of EuroSCORE II on a single-center 3800 patient cohort. Interact. Cardiovasc. Thorac. Surg. 2013; 16: 293-300.

  20. Akgul A., Gursoy M, Bakuy V., Bal Polat E, Komurcu I.G., Kavala A.A. et al. Comparison of standard Euroscore, logistic Euroscore and Euroscore II in prediction of early mortality follow­ing coronary artery bypass grafting. Anadolu Kardiyol. Derg. 2013; 13: 425-31.

  21. Shahian D.M., O'Brien S.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B. et al. Society of Thoracic Surgeons Quality Measurement Task F. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3: valve plus coronary artery bypass grafting surgery. Ann. Thorac. Surg. 2009; 88 (1): 43-62.

  22. Shahian D.M., O'Brien S.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B. et al. Society of Thoracic Surgeons Quality Measurement Task F. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1: coronary artery bypass grafting surgery. Ann. Thorac. Surg. 2009; 88 (1): 2-22.
  23. The Society of Thoracic Surgeons. (дата обращения - 13.02.2016).
  24. Yamaoka H., Kuwaki K., Inaba H., Yamamoto T., Kato T.S., Dohi S. et al. Comparison of modern risk scores in predicting operative mortality for patients undergoing aortic valve replacement for aortic stenosis. J. Cardiol. 2015. PII: S0914-5087(15) 00282-8. DOI: 10.1016/j .jjcc .2015.08.017.

  25. Sedaghat A., Sinning J.-M., Vasa-Nicotera M., Gha- nem A., Hammerstingl C., Grube E. et al. The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implan­tation. Clin. Res. Cardiol. 2013; 102 (11): 821-9.

  26. SYNTAX Score. (дата обращения - 02.02.2016).

  27. Mohr F.W., Morice M.C., Kappetein A.P., Feld­man T.E., Stahle E, Colombo A. et al. Coronary artery bypass graft surgery vs. percutaneous coro­nary intervention in patients with three-vessel dise­ase and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381 (9867): 629-38.

  28. Mohr F.W., Rastan A.J., Serruys P.W., Kappe­tein A.P., Holmes D.R., Pomar J.L. et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J. Thorac. Cardio- vasc. Surg. 2011; 141 (1): 130-40.

  29. Genereux P., Palmerini T., Caixeta A., Cristea E, Mehran R., Sanchez R. et al. SYNTAX score repro­ducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ. Cardio­vasc. Interv. 2011; 4 (6): 553-61.

  30. Papadopoulou S.L., Girasis C., Dharampal A., Farooq V., Onuma Y., Rossi A. et al. CT-SYNTAX score: a feasibility and reproducibility Study. JACC. Cardiovasc. Imaging. 2013; 6 (3): 413-5.

  31. 2014 ESC/EACTS Guidelines on myocardial revas­cularization. Eur. Heart J. 2014; 35, 2541-619.

  32. ESC Clinical Practice Guidelines, guidelines (дата обращения - 25.01.2016).

  33. Medina A., Surez de Lezo J., Pan M. A new classifi­cation of coronary bifurcation lesions. Rev. Esp. Cardiol. 2006; 59 (2): 183-4.

  34. Peterson E.D., Dai D., De Long E.R., Brennan J.M., Singh M., Rao S.V. et al. Contemporary mortality risk prediction for percutaneous coronary interven­tion: results from 588, 398 procedures in the National Cardiovascular Data Registry. J. Am. Coll. Cardiol. 2010; 55 (18): 1923-32.

  35. Ranucci M., Castelvecchio S., Menicanti L., Frigio- la A., Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009; 119 (24): 3053-61.

  36. Wykrzykowska J.J., Garg S, Onuma Y, de Vries T., Goedhart D., Morel M.A. et al. Value of age, creati­nine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trial. Circ. Cardiovasc. Interv. 2011; 4 (1): 47-56.

  37. Farooq V., Vergouwe Y., Raber L, Vranckx P, Garcia-Garcia H., Diletti R. et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percuta­neous coronary intervention: the Logistic Clinical SYNTAX score. Eur. Heart J. 2012; 33 (24): 3098-104.

  38. Farooq V., van Klaveren D., Steyerberg E.W., Me- liga E, Vergouwe Y, Chieffo A. et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percu­taneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013; 381 (9867): 639-50.

  39. Weintraub W.S., Grau-Sepulveda M.V., Weiss J.M., O'Brien S.M., Peterson E.D., Kolm P. et al. Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 2012; 366 (16): 1467-76.

  40. Chandrasekharan D.P., TaggartD.P Informed con­sent for interventions in stable coronary artery dis­ease: problems, etiologies, and solutions. Eur. J. Cardiothorac Surg. 2011; 39 (6): 912-7.

  41. Health at a Glance 2009: OECD Indicators, OECD Publishing, Paris; 2009.

  42. Hannan E.L., Cozzens K., Samadashvili Z., Wal- ford G., Jacobs A.K., Holmes D.R. Jr. et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J. Am. Coll. Cardiol. 2012; 59 (21): 1870-6.

  43. Frutkin A.D., Lindsey J.B., Mehta S.K., House J.A., Spertus J.A., Cohen D.J. et al. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascular­ization: analysis from the NCDR (National Cardiovascular Data Registry). JACC. Cardiovasc. Interv. 2009; 2 (7): 614-21.

  44. Griffin S.C., Barber J.A., Manca A. et al. Cost effec­tiveness of clinically appropriate decisions on alter­native treatments for angina pectoris: prospective observational study. Br. Med. J. 2007; 334: 624-7.

  45. Taggart D.P. Coronary artery bypass graft vs. percu­taneous coronary angioplasty: CABG on the rebound? Curr. Opin. Cardiol. 2007; 22: 517-23.

  46. Yates M.T., Soppa G.K., Valencia O., Jones S., Firoozi S., Jahangiri M. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease. J. Thorac. Cardiovasc. Surg. 2014; 147 (2): 606-10.

  47.  Epstein A.J., Polsky D., Yang F., Yang L., Groene- veld P.W. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011; 305 (17): 1769-76.

  48. Hannan E.L., Racz M.J., Gold J., Cozzens K., Stama- to N.J., Powell T. et al. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coro­nary artery bypass graft surgery: what happens in actual practice? Circulation. 2010; 121 (2): 267-75.

  49. Boden W.E. Which is more enduring - FAME or COURAGE? N. Engl. J. Med. 2012; 367: 1059-61.

  50. Sumin A.N., Bezdenezhnykh N.A., Bezdenezh­nykh A.V., Ivanov S.V., Barbarash O.L. Peripheral atherosclerosis, diabetes and long-term results of coronary artery bypass grafting. Kreativnaya kardio- logiya. 2014; 4: 5-17 (in Russian).

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery